- Home
- ELME vs VRDN Comparison
ELME vs VRDN Comparison
Compare ELME & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELME
- VRDN
- Stock Information
- Founded
- ELME 1960
- VRDN 2006
- Country
- ELME United States
- VRDN United States
- Employees
- ELME N/A
- VRDN N/A
- Industry
- ELME Real Estate Investment Trusts
- VRDN Medical Specialities
- Sector
- ELME Real Estate
- VRDN Health Care
- Exchange
- ELME Nasdaq
- VRDN Nasdaq
- Market Cap
- ELME 1.5B
- VRDN 1.5B
- IPO Year
- ELME N/A
- VRDN N/A
- Fundamental
- Price
- ELME $16.16
- VRDN $20.20
- Analyst Decision
- ELME Hold
- VRDN Strong Buy
- Analyst Count
- ELME 5
- VRDN 10
- Target Price
- ELME $17.50
- VRDN $37.25
- AVG Volume (30 Days)
- ELME 587.6K
- VRDN 1.2M
- Earning Date
- ELME 11-04-2024
- VRDN 11-12-2024
- Dividend Yield
- ELME 4.46%
- VRDN N/A
- EPS Growth
- ELME N/A
- VRDN N/A
- EPS
- ELME N/A
- VRDN N/A
- Revenue
- ELME $239,523,000.00
- VRDN $302,000.00
- Revenue This Year
- ELME N/A
- VRDN N/A
- Revenue Next Year
- ELME $2.78
- VRDN N/A
- P/E Ratio
- ELME N/A
- VRDN N/A
- Revenue Growth
- ELME 6.62
- VRDN N/A
- 52 Week Low
- ELME $12.74
- VRDN $11.40
- 52 Week High
- ELME $18.49
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- ELME 40.28
- VRDN 39.09
- Support Level
- ELME $15.56
- VRDN $19.65
- Resistance Level
- ELME $17.89
- VRDN $20.87
- Average True Range (ATR)
- ELME 0.43
- VRDN 1.36
- MACD
- ELME -0.11
- VRDN -0.45
- Stochastic Oscillator
- ELME 25.75
- VRDN 9.79
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located primarily near major transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's largest tenants are banking, consulting, law, and financial services firms.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.